GENE ONLINE|News &
Opinion
Blog

Crohn’s disease
Teva and Sanofi’s Best-in-Class IBD Drug a Game-Changer in the Antibody Therapeutics Arena
2024-12-18
The First and Only FDA-approved Drug for Chronic Digestive Diseases by Celltrion USA
2023-10-25
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
R&D
Lilly’s Investigational Monoclonal Antibody Registers Symptom Improvement in Crohn’s Disease Patients
2020-10-13
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
Finch’s First Microbial Cocktail Treating Clostridium Infection Registers Positive Results
2020-06-24
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
Weekly in Asia(0428-0503)
2019-05-09
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top